Central effects of a series of N1-, N4-acyl piperazine derivatives.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D006591:Hexobarbital / Q000037:antagonists & inhibitors; D006801:Humans; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010879:Piperazines / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D011889:Rage / Q000187:drug effects; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012640:Seizures / Q000517:prevention & control; D013239:Stereotyped Behavior / Q000187:drug effects; D013331:Strychnine / Q000037:antagonists & inhibitors
D010879:Piperazines; D012110:Reserpine; D006591:Hexobarbital; D013331:Strychnine; D010433:Pentylenetetrazole